112 related articles for article (PubMed ID: 15313406)
21. Menatetrenone, a vitamin K2 analogue, inhibits hepatocellular carcinoma cell growth by suppressing cyclin D1 expression through inhibition of nuclear factor kappaB activation.
Ozaki I; Zhang H; Mizuta T; Ide Y; Eguchi Y; Yasutake T; Sakamaki T; Pestell RG; Yamamoto K
Clin Cancer Res; 2007 Apr; 13(7):2236-45. PubMed ID: 17404108
[TBL] [Abstract][Full Text] [Related]
22. Magnolol suppresses NF-kappaB activation and NF-kappaB regulated gene expression through inhibition of IkappaB kinase activation.
Tse AK; Wan CK; Zhu GY; Shen XL; Cheung HY; Yang M; Fong WF
Mol Immunol; 2007 Apr; 44(10):2647-58. PubMed ID: 17240450
[TBL] [Abstract][Full Text] [Related]
23. Regulation of lipopolysaccharide-induced inflammatory response by glutathione S-transferase P1 in RAW264.7 cells.
Xue B; Wu Y; Yin Z; Zhang H; Sun S; Yi T; Luo L
FEBS Lett; 2005 Aug; 579(19):4081-7. PubMed ID: 16023107
[TBL] [Abstract][Full Text] [Related]
24. Roles of ERK and p38 mitogen-activated protein kinases in phorbol ester-induced NF-kappaB activation and COX-2 expression in human breast epithelial cells.
Kim JH; Na HK; Pak YK; Lee YS; Lee SJ; Moon A; Surh YJ
Chem Biol Interact; 2008 Jan; 171(2):133-41. PubMed ID: 17767925
[TBL] [Abstract][Full Text] [Related]
25. Tumor necrosis factor-alpha induced the release of interleukin-6 from endometriotic stromal cells by the nuclear factor-kappaB and mitogen-activated protein kinase pathways.
Yamauchi N; Harada T; Taniguchi F; Yoshida S; Iwabe T; Terakawa N
Fertil Steril; 2004 Oct; 82 Suppl 3():1023-8. PubMed ID: 15474068
[TBL] [Abstract][Full Text] [Related]
26. Involvement of nuclear factor kappaB in up-regulation of aldose reductase gene expression by 12-O-tetradecanoylphorbol-13-acetate in HeLa cells.
Lee YS; Paek KS; Kang ES; Jang HS; Kim HJ; Kang YJ; Kim JH; Lee HT; Lee JH; Chang KC; Nishinaka T; Seo HG
Int J Biochem Cell Biol; 2005 Nov; 37(11):2297-309. PubMed ID: 15936242
[TBL] [Abstract][Full Text] [Related]
27. Tumor necrosis factor alpha induces gamma-glutamyltransferase expression via nuclear factor-kappaB in cooperation with Sp1.
Reuter S; Schnekenburger M; Cristofanon S; Buck I; Teiten MH; Daubeuf S; Eifes S; Dicato M; Aggarwal BB; Visvikis A; Diederich M
Biochem Pharmacol; 2009 Feb; 77(3):397-411. PubMed ID: 18996094
[TBL] [Abstract][Full Text] [Related]
28. L-ascorbic acid represses constitutive activation of NF-kappaB and COX-2 expression in human acute myeloid leukemia, HL-60.
Han SS; Kim K; Hahm ER; Lee SJ; Surh YJ; Park HK; Kim WS; Jung CW; Lee MH; Park K; Yang JH; Yoon SS; Riordan NH; Riordan HD; Kimler BF; Park CH; Lee JH; Park S
J Cell Biochem; 2004 Oct; 93(2):257-70. PubMed ID: 15368354
[TBL] [Abstract][Full Text] [Related]
29. Genetic deletion of PKR abrogates TNF-induced activation of IkappaBalpha kinase, JNK, Akt and cell proliferation but potentiates p44/p42 MAPK and p38 MAPK activation.
Takada Y; Ichikawa H; Pataer A; Swisher S; Aggarwal BB
Oncogene; 2007 Feb; 26(8):1201-12. PubMed ID: 16924232
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of TNFalpha-induced activation of nuclear factor kappaB by kava (Piper methysticum) derivatives.
Folmer F; Blasius R; Morceau F; Tabudravu J; Dicato M; Jaspars M; Diederich M
Biochem Pharmacol; 2006 Apr; 71(8):1206-18. PubMed ID: 16464438
[TBL] [Abstract][Full Text] [Related]
31. Diverse effects of zinc on NF-kappaB and AP-1 transcription factors: implications for prostate cancer progression.
Uzzo RG; Crispen PL; Golovine K; Makhov P; Horwitz EM; Kolenko VM
Carcinogenesis; 2006 Oct; 27(10):1980-90. PubMed ID: 16606632
[TBL] [Abstract][Full Text] [Related]
32. TNF-alpha induces transient resistance to Fas-induced apoptosis in eosinophilic acute myeloid leukemia cells.
Qin Y; Auh S; Blokh L; Long C; Gagnon I; Hamann KJ
Cell Mol Immunol; 2007 Feb; 4(1):43-52. PubMed ID: 17349210
[TBL] [Abstract][Full Text] [Related]
33. Hesperidin inhibited acetaldehyde-induced matrix metalloproteinase-9 gene expression in human hepatocellular carcinoma cells.
Yeh MH; Kao ST; Hung CM; Liu CJ; Lee KH; Yeh CC
Toxicol Lett; 2009 Feb; 184(3):204-10. PubMed ID: 19110045
[TBL] [Abstract][Full Text] [Related]
34. Mitochondrial reactive oxygen species regulate the temporal activation of nuclear factor kappaB to modulate tumour necrosis factor-induced apoptosis: evidence from mitochondria-targeted antioxidants.
Hughes G; Murphy MP; Ledgerwood EC
Biochem J; 2005 Jul; 389(Pt 1):83-9. PubMed ID: 15727562
[TBL] [Abstract][Full Text] [Related]
35. Suppression of the NF-kappaB signalling pathway by ergolide, sesquiterpene lactone, in HeLa cells.
Chun JK; Seo DW; Ahn SH; Park JH; You JS; Lee CH; Lee JC; Kim YK; Han JW
J Pharm Pharmacol; 2007 Apr; 59(4):561-6. PubMed ID: 17430640
[TBL] [Abstract][Full Text] [Related]
36. cis-9,trans-11-conjugated linoleic acid down-regulates phorbol ester-induced NF-kappaB activation and subsequent COX-2 expression in hairless mouse skin by targeting IkappaB kinase and PI3K-Akt.
Hwang DM; Kundu JK; Shin JW; Lee JC; Lee HJ; Surh YJ
Carcinogenesis; 2007 Feb; 28(2):363-71. PubMed ID: 16950795
[TBL] [Abstract][Full Text] [Related]
37. Effect of curcumin on nuclear factor kappaB signaling pathways in human chronic myelogenous K562 leukemia cells.
Reuter S; Charlet J; Juncker T; Teiten MH; Dicato M; Diederich M
Ann N Y Acad Sci; 2009 Aug; 1171():436-47. PubMed ID: 19723087
[TBL] [Abstract][Full Text] [Related]
38. Inhibitory role of magnolol on proliferative capacity and matrix metalloproteinase-9 expression in TNF-alpha-induced vascular smooth muscle cells.
Kim HM; Bae SJ; Kim DW; Kim BK; Lee SB; Lee US; Kim CH; Moon SK
Int Immunopharmacol; 2007 Aug; 7(8):1083-91. PubMed ID: 17570325
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of activator protein-1, NF-kappaB, and MAPKs and induction of phase 2 detoxifying enzyme activity by chlorogenic acid.
Feng R; Lu Y; Bowman LL; Qian Y; Castranova V; Ding M
J Biol Chem; 2005 Jul; 280(30):27888-95. PubMed ID: 15944151
[TBL] [Abstract][Full Text] [Related]
40. Reversal of multiple drug resistance in cholangiocarcinoma by the glutathione S-transferase-pi-specific inhibitor O1-hexadecyl-gamma-glutamyl-S-benzylcysteinyl-D-phenylglycine ethylester.
Nakajima T; Takayama T; Miyanishi K; Nobuoka A; Hayashi T; Abe T; Kato J; Sakon K; Naniwa Y; Tanabe H; Niitsu Y
J Pharmacol Exp Ther; 2003 Sep; 306(3):861-9. PubMed ID: 12805482
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
